Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07175129 · ClinicalTrials.gov registry record · NA
Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)
A NA study of Chronic Limb-Threatening Ischemia, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07175129 is a NA study of Chronic Limb-Threatening Ischemia that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 10 participants, below the 184-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07175129, a NA study of Chronic Limb-Threatening Ischemia, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease that doctors are unable to restore blood flow using standard treatments like surgery or stents. For these patients, major amputation may be the only remaining option. This study aims to test a new surgical technique called transverse tibial bone transport, which has been shown in some previous small studies to help improve blood flow and promote healing of wounds in the legs and feet. These early studies suggest that the procedure may help wounds heal better and reduce the need for amputation in people with severe circulation problems. This research will help us learn more about how safe and effective this technique is for patients who have no other treatment options other than amputation.
Conditions Studied
Interventions
- PROCEDURE Transverse Tibial Bone Transport
- DEVICE TrueLok Elevate
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07175129
The ClinicalTrials.gov registry entry for NCT07175129 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 184-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (95% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Limb-Threatening Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Transverse Tibial Bone Transport is the first listed.
NCT07175129 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07175129 about?
NCT07175129 is a clinical study titled "Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)". Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease...
What is the current status of trial NCT07175129?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01-05. Estimated completion is 2027-06.
What conditions does trial NCT07175129 study?
This clinical trial studies the following conditions: Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT07175129?
The interventions under investigation include: Transverse Tibial Bone Transport (PROCEDURE), TrueLok Elevate (DEVICE).
Who is sponsoring clinical trial NCT07175129?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07175129 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Limb-Threatening Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
RECRUITING · NA
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
AcoArt Litos PCB Below-the-knee Global Trial
RECRUITING · NA
-
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
RECRUITING · NA
-
Esprit BTK Post-Approval Study
RECRUITING · NA
-
The ROAMM-EHR Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.